Anna Törner: Success requires bold decisions!

“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.

Marie Gårdmark: Finally, it’s time for a revision of the EU pharma legislation

A challenge for the EU Commission is to deliver a new framework that will also take care of another “pillar” of the pharmaceutical strategy, namely, to ensure t...

Upcoming event: New updates on drugs

At Medicon Valley Alliance venues in Copenhagen/Örestad April 1 2020 the meeting New updates in Drug Formulation & Bioavailability takes place for the for the eighth time.

Björn Arvidsson: Let's build on the positive momentum

Progress needs narratives and heroes, and more than ever, going into the new year feels like an opportunity for a fresh start.

Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

Elicera develops CAR-T against solid tumours – may become the first in the world

Today, there are five EU-approved CAR-T therapies, all focused on different types of blood cancer, but no one has yet succeeded in making the method work agains...

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Biosimilars bring price pressure, but are they sufficiently used?

When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...

Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system

Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to ...

Drug development creates new challenges for regulators

Pilots want to live too

They’re all doing it – buying drug research

December 12 the time has come for this year's annual partnering meeting Pharma Outsourcing in Stockholm. In Sweden this is a growing business, with Recipharm as...

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Algextrakt kan bli läkemedel

Algen Dunaliella salina klarar av att växa i några av jordens tuffaste miljöer, från saltgrottor i Antarktis till saltslätter i tropikerna och den innehåller må...

Peab-grundarens stiftelse ger 22 miljoner till life science

Nya behandlingmetoder av cancer, blodbrist och herpesvirus, nya tekniker för kartläggning av gener och upptäckt av sårinfektioner och ett växtbaserat järntillsk...

New firm based on SLU research

Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.

Stipendium till diagnostikbolag

Siktar på att få ut produkt på marknaden inom några år.

It´s time to establish relations

Communication with the patient is the key to future healthcare, writes Hanna Brodda, editor in chief of Life Science Sweden.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

Så hittar du uppköpskandidater

Att investera i bolag på börsen som kan bli uppköpta kan vara en investeringsstrategi att få en snabb avkastning på sitt investerade kapital.

640 miljoner till forskningsprojekt

Knut och Alice Wallenbergs Stiftelse har beviljat totalt 640 miljoner kronor till 22 forskningsprojekt varav flera inom medicin som bedöms ha möjlighet att leda...

Pengaregn över hälsoprojekt

22 projekt inom läkemedel, medtech och e-hälsa delar på 20,5 miljoner i Vinnova-utlysning.

Bought a tablet factory – and built his own empire

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...